A detailed history of Fmr LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Fmr LLC holds 4,407,695 shares of BEAM stock, worth $101 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,407,695
Previous 4,894,453 9.95%
Holding current value
$101 Million
Previous $162 Million 36.14%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$21.22 - $32.66 $10.3 Million - $15.9 Million
-486,758 Reduced 9.95%
4,407,695 $103 Million
Q1 2024

May 13, 2024

SELL
$23.46 - $45.07 $30.2 Million - $58 Million
-1,285,869 Reduced 20.81%
4,894,453 $162 Million
Q4 2023

Feb 13, 2024

SELL
$17.69 - $30.76 $5.62 Million - $9.77 Million
-317,509 Reduced 4.89%
6,180,322 $168 Million
Q3 2023

Nov 13, 2023

SELL
$23.01 - $32.46 $14.7 Million - $20.8 Million
-639,878 Reduced 8.96%
6,497,831 $156 Million
Q2 2023

Aug 11, 2023

BUY
$29.32 - $35.99 $30.8 Million - $37.8 Million
1,050,156 Added 17.25%
7,137,709 $228 Million
Q1 2023

May 11, 2023

BUY
$30.15 - $48.79 $33.8 Million - $54.7 Million
1,121,564 Added 22.58%
6,087,553 $186 Million
Q4 2022

Feb 13, 2023

BUY
$36.73 - $51.6 $14 Million - $19.7 Million
381,854 Added 8.33%
4,965,989 $194 Million
Q3 2022

Nov 10, 2022

SELL
$39.79 - $70.31 $8.59 Million - $15.2 Million
-215,964 Reduced 4.5%
4,584,135 $218 Million
Q2 2022

Aug 12, 2022

SELL
$29.86 - $62.36 $18.4 Million - $38.4 Million
-614,997 Reduced 11.36%
4,800,099 $186 Million
Q1 2022

May 13, 2022

BUY
$53.73 - $82.16 $80.3 Million - $123 Million
1,493,793 Added 38.09%
5,415,096 $310 Million
Q4 2021

Feb 14, 2022

SELL
$68.02 - $99.06 $194,741 - $283,608
-2,863 Reduced 0.07%
3,921,303 $312 Million
Q3 2021

Nov 15, 2021

SELL
$84.37 - $133.6 $317 Million - $502 Million
-3,761,094 Reduced 48.94%
3,924,166 $341 Million
Q2 2021

Aug 13, 2021

BUY
$64.12 - $128.71 $493 Million - $989 Million
7,685,260 New
7,685,260 $989 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.61B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.